Wealth Advisory Solutions, LLC Abb Vie Inc. Transaction History

Wealth Advisory Solutions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $228,311 - $290,258	1,659 New	1,659 $254,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $893,900 - $1.11 Million	-6,773 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $467,628 - $530,828	4,395 Added 184.82%	6,773 $731,000
Q2 2021 Jul 21, 2021	SELL	$105.21 - $117.21 $531,941 - $592,613	-5,056 Reduced 68.01%	2,378 $268,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $760,498 - $837,217	7,434 New	7,434 $804,000
Q3 2020 Dec 29, 2020	SELL	$85.91 - $100.83 $197,335 - $231,606	-2,297 Closed	0 $0
Q2 2020 Dec 23, 2020	BUY	$73.37 - $98.18 $168,530 - $225,519	2,297 New	2,297 $226,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wealth Advisory Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisory Solutions, LLC with notifications on news.